NCT00319033View on ClinicalTrials.gov

Open-label Study With Bosentan in Interstitial Lung Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Interstitial Lung DiseaseScleroderma
Interventions
DRUG

bosentan

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00319033 - Open-label Study With Bosentan in Interstitial Lung Disease | Biotech Hunter | Biotech Hunter